Rooney CM - Search Results

1

Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir.

Sung JA, Lam S, Garrido C, Archin N, Rooney CM, Bollard CM, Margolis DM. Sung JA, et al. Among authors: rooney cm. J Infect Dis. 2015 Jul 15;212(2):258-63. doi: 10.1093/infdis/jiv022. Epub 2015 Jan 13. J Infect Dis. 2015. PMID: 25589335 Free PMC article.

2

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

3

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: rooney cm. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

4

Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy.

Rossig C, Bollard CM, Nuchtern JG, Rooney CM, Brenner MK. Rossig C, et al. Among authors: rooney cm. Blood. 2002 Mar 15;99(6):2009-16. doi: 10.1182/blood.v99.6.2009. Blood. 2002. PMID: 11877273 Free article.

5

Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity.

Bollard CM, Rössig C, Calonge MJ, Huls MH, Wagner HJ, Massague J, Brenner MK, Heslop HE, Rooney CM. Bollard CM, et al. Among authors: rooney cm. Blood. 2002 May 1;99(9):3179-87. doi: 10.1182/blood.v99.9.3179. Blood. 2002. PMID: 11964281 Free article.

6

Immune therapy for EBV infections after hemopoietic stem-cell transplant.

Heslop HE, Bollard CM, Gottschalk S, Kuehnle I, Huls MH, Gee AP, Brenner MK, Rooney CM. Heslop HE, et al. Among authors: rooney cm. Cytotherapy. 2002;4(5):433-4. doi: 10.1080/146532402320776071. Cytotherapy. 2002. PMID: 12473214 Review. No abstract available.

7

Immunotherapy for Epstein-Barr virus-associated cancers in children.

Straathof KC, Bollard CM, Rooney CM, Heslop HE. Straathof KC, et al. Among authors: rooney cm. Oncologist. 2003;8(1):83-98. doi: 10.1634/theoncologist.8-1-83. Oncologist. 2003. PMID: 12604735 Free article. Review.

8

Immunotherapy for Hodgkin's disease.

Rooney CM, Bollard C, Huls MH, Gahn B, Gottschalk S, Wagner HJ, Anderson R, Prentice HG, Brenner MK, Heslop HE. Rooney CM, et al. Ann Hematol. 2002;81 Suppl 2:S39-42. Ann Hematol. 2002. PMID: 12611071

9

Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.

Bollard CM, Savoldo B, Rooney CM, Heslop HE. Bollard CM, et al. Among authors: rooney cm. Acta Haematol. 2003;110(2-3):139-48. doi: 10.1159/000072463. Acta Haematol. 2003. PMID: 14583674 Review.

10

A strategy for treatment of Epstein-Barr virus-positive Hodgkin's disease by targeting interleukin 12 to the tumor environment using tumor antigen-specific T cells.

Wagner HJ, Bollard CM, Vigouroux S, Huls MH, Anderson R, Prentice HG, Brenner MK, Heslop HE, Rooney CM. Wagner HJ, et al. Among authors: rooney cm. Cancer Gene Ther. 2004 Feb;11(2):81-91. doi: 10.1038/sj.cgt.7700664. Cancer Gene Ther. 2004. PMID: 14685154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters